In both TCGA and Gravendeel cohorts, gliomas with a STAT3high gene signature (associated with inferior glioma patient survival and GBM [39]) significantly expressed higher E2F1 and H2AZ2 levels than tumors with a STAT3low gene signature (Fig. 7G, H). Here, E2F1 is linked to central nervous system cancer.